Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients with Non-Specific CLBP

Description

This is a prospective, sham-controlled, randomized, single-blinded, multi-center study comparing two different modes of the NexWave device, transcutaneous electrical nerve stimulation (TENS) and interferential current (IFC), with an identical non-functioning NexWave sham device or self-defined standard of care for improvement of pain intensity of non-specific CLBP.

Conditions

Non-Specific Chronic Lower Back Pain

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a prospective, sham-controlled, randomized, single-blinded, multi-center study comparing two different modes of the NexWave device, transcutaneous electrical nerve stimulation (TENS) and interferential current (IFC), with an identical non-functioning NexWave sham device or self-defined standard of care for improvement of pain intensity of non-specific CLBP.

Randomized Blinded Evaluation of the Effects of Transcutaneous Electrical Nerve Stimulation and Interferential Current Compared to a Sham Device and Standard of Care in Patients with Non-Specific Chronic Lower Back Pain

Randomized Blinded Evaluation of the Effects of TENS and IFC Compared to a Sham Device and SOC in Patients with Non-Specific CLBP

Condition
Non-Specific Chronic Lower Back Pain
Intervention / Treatment

-

Contacts and Locations

Greenwood Village

DBPS Research, Greenwood Village, Colorado, United States, 80111

Saint Augustine

McGreevy NeuroHealth, Saint Augustine, Florida, United States, 32095

Atlanta

Peachtree Orthopedics, Atlanta, Georgia, United States, 30327

Jasper

Horizon Clinical Research, Jasper, Georgia, United States, 30143

Bloomington

Applied Pain Institute, LLC, Bloomington, Illinois, United States, 61701

Catonsville

CAO Research Foundation, Catonsville, Maryland, United States, 21228

Congers

One Oak Medical, Congers, New York, United States, 10920

Winston-Salem

The Center for Clinical Research, LLC, Winston-Salem, North Carolina, United States, 27103

Lehi

Summit Brain, Spine and Orthopedics, Lehi, Utah, United States, 84043

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Ages 18-70, or older if specified by law
  • * Non-specific chronic lower back pain defined as:
  • 1. Having lasted ≥3 months in duration
  • 2. Current Visual Analogue Scale (VAS) pain rating ≥50 out of 100 (or an equivalent of 5 out of 10 on a 10-point scale)
  • 3. No radiating pain below the knee
  • 4. ≥75% back or buttock pain rather than lower extremity pain
  • * Subjects who are willing and capable of providing informed consent
  • * Subjects who are willing and capable of participating in all testing and questionnaire requirements associated with the clinical study
  • * Any prior home use of the NexWave or any TENS/IFC device
  • * Any history of lumbar spine surgery or spinal fractures
  • * Subjects with a history of rheumatic disease
  • * Subjects with spine disorders, deformities, or severe spinal conditions such as scoliosis and kyphosis, Pott's disease, disc protrusion, or others that can be attributed to specific causes of back pain
  • * Subjects currently prescribed and adherent to opioid therapy
  • * Current implanted cardiac pacemakers, defibrillators, cardiac pumps, spinal stimulators, or other implanted electronic devices
  • * Active psychiatric or uncontrolled mood disorders including subjects on antipsychotic medication, diagnosis of bipolar disorder or schizophrenia, or uncontrolled anxiety or clinical depression
  • * Subjects with a known history of allergic reactions to medical adhesives or any condition that could affect placement of the electrodes
  • * Women of childbearing potential who are pregnant or who are planning to become pregnant during the anticipated study period
  • * Subjects with health conditions that in the Investigator's medical opinion would prevent participation in the study, interfere with assessment or therapy, significantly raise the risk of study participation, or modify outcome data or its interpretation
  • * Subjects who are currently enrolled in another investigational study that would directly interfere with the current study

Ages Eligible for Study

18 Years to 70 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Zynex Medical, Inc.,

James M. North, MD, PRINCIPAL_INVESTIGATOR, The Center for Clinical Research

Study Record Dates

2024-12-31